Craig Fraser Windtree Therapeutics Inc (WINT) insider trading activity

WINT Quotes by TradingView

Craig Fraser is President and CEO of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 8,638 shares of WINT, which is worth approximately $2,764. The most recent transaction as insider was on Oct 08, 2024, when has been sold 5,431 shares (Common Stock) at a price of $0.91 per share, resulting in proceeds of $4,942. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.64K
85.08% 3M change
85.08% 12M change
Total Value Held $2,764

Craig Fraser Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2024
BUY
Open market or private purchase
$4,942 $0.91 p/Share
5,431 Added 38.6%
8,638 Common Stock
Sep 27 2023
BUY
Open market or private purchase
$2,550 $1.02 p/Share
2,500 Added 4.14%
57,877 Common Stock
Sep 26 2023
BUY
Open market or private purchase
$2,250 $0.9 p/Share
2,500 Added 4.32%
55,377 Common Stock
Aug 23 2023
BUY
Grant, award, or other acquisition
-
45,867 Added 46.45%
52,877 Common Stock
Apr 26 2023
BUY
Open market or private purchase
$2,649 $1.77 p/Share
1,497 Added 17.6%
7,010 Common Stock
Apr 25 2023
BUY
Open market or private purchase
$2,485 $1.89 p/Share
1,315 Added 19.26%
5,513 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
-
334 Reduced 7.37%
4,198 Common Stock
Jul 27 2022
BUY
Open market or private purchase
$950 $0.38 p/Share
2,500 Added 1.09%
226,558 Common Stock
Jul 26 2022
BUY
Open market or private purchase
$925 $0.37 p/Share
2,500 Added 1.1%
224,058 Common Stock
Jun 30 2022
BUY
Open market or private purchase
$1,935 $0.43 p/Share
4,500 Added 1.99%
221,558 Common Stock
Jun 29 2022
BUY
Open market or private purchase
$2,940 $0.42 p/Share
7,000 Added 3.12%
217,058 Common Stock
Mar 16 2022
BUY
Open market or private purchase
$1,960 $0.98 p/Share
2,000 Added 0.94%
210,058 Common Stock
Mar 15 2022
BUY
Open market or private purchase
$2,940 $0.98 p/Share
3,000 Added 1.42%
208,058 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
166,900 Added 44.87%
205,058 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$1,488 $1.6 p/Share
930 Added 2.38%
38,158 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$1,497 $1.61 p/Share
930 Added 2.44%
37,228 Common Stock
Oct 22 2021
BUY
Open market or private purchase
$5,700 $1.9 p/Share
3,000 Added 7.63%
36,298 Common Stock
Oct 19 2021
BUY
Open market or private purchase
$5,730 $1.91 p/Share
3,000 Added 8.26%
33,298 Common Stock
Apr 16 2021
BUY
Open market or private purchase
$2,090 $2.09 p/Share
1,000 Added 3.2%
30,298 Common Stock
Apr 15 2021
BUY
Open market or private purchase
$2,240 $2.24 p/Share
1,000 Added 3.3%
29,298 Common Stock
Apr 06 2021
BUY
Open market or private purchase
$1,285 $2.57 p/Share
500 Added 1.74%
28,298 Common Stock
Apr 05 2021
BUY
Open market or private purchase
$2,580 $2.58 p/Share
1,000 Added 3.47%
27,798 Common Stock
Apr 01 2021
BUY
Open market or private purchase
$1,230 $2.46 p/Share
500 Added 1.83%
26,798 Common Stock
Mar 31 2021
BUY
Open market or private purchase
$1,160 $2.32 p/Share
500 Added 1.87%
26,298 Common Stock
Mar 25 2021
BUY
Open market or private purchase
$4,875 $3.25 p/Share
1,500 Added 5.49%
25,798 Common Stock
CF

Craig Fraser

President and CEO
Warrington, PA

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on WINT